New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

Bastos-Oreiro, Mariana; Abrisqueta, Pau; Gutiérrez, Antonio; Jiménez-Ubieto, Ana; Poza, María; Fernanez-Caldas, Paula; LLacer, María-José; González-de-Villambrosía, Sonia; Córdoba, Raúl; López, Alberto; Ceballos, Elena; Navarro, Belén; Muntañola, Ana; Donato, Eva; Díez-Baeza, Eva; Escoda, Lourdes; Luzardo, Hugo; Peñarrubia, María-José; García-Belmonte, Daniel; Pardal, Emilia; Lozada, Claudia; Martín-García-Sancho, Alejandro

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.06. Área de Salud VI Vega Media
→
02.06.01. Investigación y comunicación científica
→
Ver ítem

New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group

Bastos-Oreiro, Mariana; Abrisqueta, Pau; Gutiérrez, Antonio; Jiménez-Ubieto, Ana; Poza, María; Fernanez-Caldas, Paula; LLacer, María-José; González-de-Villambrosía, Sonia; Córdoba, Raúl; López, Alberto; Ceballos, Elena; Navarro, Belén; Muntañola, Ana; Donato, Eva; Díez-Baeza, Eva; Escoda, Lourdes; Luzardo, Hugo; Peñarrubia, María-José; García-Belmonte, Daniel; Pardal, Emilia; Lozada, Claudia; Martín-García-Sancho, Alejandro

URI: https://sms.carm.es/ricsmur/handle/123456789/20862

Fecha: 2024

Resumen:

To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and integrase strand transfer inhibitors (INSTI) in Spain during the period 2019-2021

Mostrar el registro completo del ítem